Technical Articles

The KRAS gene is one of the most common oncogenes in human cancers, frequently mutated in various solid tumors such as pancreatic cancer, colorectal cancer, and lung cancer.

The KRAS G12V mutation is one of the most common driver mutations in refractory tumors such as pancreatic cancer and lung cancer. Due to the intracellular localization of the KRAS protein, traditional antibody drugs struggle to directly target it, making this target a long-standing therapeutic challenge.

Mouse Lung Organoids, as an emerging three-dimensional in vitro model system, are becoming an important tool for respiratory disease research and drug screening.

PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein is a high-performance fluorescently labeled fusion protein that plays a significant role in the research and therapeutic development of various epithelial-derived tumors, including colorectal cancer, gastric cancer, and lung cancer.

Neuroregulatory protein 1 (NRG1) fusion, as a rare oncogenic driving mechanism, has received widespread attention in research on non-small cell lung cancer (NSCLC) in recent years. NRG1 fusion promotes tumor occurrence and development by abnormally activating the epidermal growth factor receptor (EGFR) family signaling pathway, providing a new direction for precision treatment of lung cancer